Get started
Author

He Dou

ORCID: 0000-0002-5317-8289
Observed ORCID: 0000-0002-5317-8289
OpenAlex ID: A5047928604
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
2023 · Zhennan Yuan, Yingpu Li, et al. · Molecular Cancer · 963
PDF
Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment
2020 · Shan-Shan Yang, Shuang Ma, et al. · Experimental Cell Research · 169
Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review
2023 · He Dou, Ping yang Yu, et al. · Journal of Chemotherapy · 47
PDF
Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy
2024 · Fucheng Li, Youyu Wang, et al. · Frontiers in Oncology · 22
PDF
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
2024 · He Dou, Fucheng Li, et al. · Diagnostic Pathology · 19
PDF
[Retracted] Breast Cancer Exosome‐Derived miR‐425‐5p Induces Cancer‐Associated Fibroblast‐Like Properties in Human Mammary Fibroblasts by TGFβ1/ROS Signaling Pathway
2022 · Yue Zhu, He Dou, et al. · Oxidative Medicine and Cellular Longevity · 16
PDF
Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach
2023 · Yue Zhu, Xingyan Chen, et al. · Frontiers in Oncology · 9
PDF
Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy
2025 · Fucheng Li, Tian Gao, et al. · Translational Oncology · 8
Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer
2025 · Jing Qi Xia, Yi Lin Wang, et al. · BMC Women s Health · 6
PDF
Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer
2023 · He Dou, Siyuan Jia, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Comparison of clinical characteristics and pathologic complete response rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer
2024 · He Dou, Tian Gao, et al. · Gland Surgery · 1
Impact of changes in serum lactate dehydrogenase levels on pathological response after neoadjuvant chemotherapy in patients with breast cancer
2024 · He Dou, Si yuan Jia, et al. · Research Square
PDF
Comparison of clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer
2024 · He Dou, Tian Gao, et al. · Research Square
PDF
Risk factors of breast malignant lesions in patients with ultrasound BI-RADS 3, 4a and 4b undergoing Mammotome minimally invasive surgery
2023 · Yue Zhu, Xingyan Chen, et al. · Research Square
PDF
Comparison of clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in very young women and older women with breast cancer
2022 · He Dou, Yu qi Liu, et al. · Research Square
PDF
Works count: 15
Citation count: 1,264
H-index: 8
I10-index: 6
Year
Topic
Type